Switching is possible from an antipsychotic with a high metabolic risk such as olanzapine, quetiapine, or risperidone to one with a lower risk, such as aripiprazole, a new study (see link) shows.
American Journal of Psychiatry (online 18 July)
The content on this site is available to Australian Registered Health Practitioners only.
To continue reading please login or register for access.